Table 2. Hemodynamic variables at time points t ₁ through t ₄.

	All (n = 12)	Diabetics (n = 5)	Non-Diabetics (n = 7)	p+
MAP (mmHg)
t1	114 .2 ± 16.8	116.0 ± 3.4	112.9 ± 22.4	0.77
t2	110.4 ± 16.9	114.9 ± 9.2	107.2 ± 20.9	0.46
t3	109.7 ± 23.1	115.6 ± 26.4	105.5 ± 21.5	0.48
t4	111.7 ± 22.4	116.8 ± 18.9	108.1 ± 25.4	0.53
p*	0.71	0.99	0.14
HR (1/min)
t1	70.5 ± 11.4	65.5 ± 14.5	74.0 ± 7.9	0.22
t2	69.6 ± 12.9	64.7 ± 14.7	73.2 ± 11.3	0.28
t3	69.3 ± 13.3	64.0 ± 18.7	73.1 ± 7.3	0.26
t4	72.1 ± 15.2	66.2 ± 22.1	76.3 ± 6.7	0.28
p*	0.82	0.89	0.49
Hct (%)
t1	35.13 ± 2.13	35.73 ± 2.51	34.70 ± 1.90	0.44
t2	35.67 ± 2.18	36.29 ± 2.70	35.22 ± 1.81	0.43
t3	35.62 ± 1.83	35.52 ± 2.40	35.69 ± 1.51	0.88
t4	36.72 ± 2.01	37.57 ± 2.38	36.11 ± 1.62	0.23
p*	0.003	0.17	< 0.001
Vp (L)
t1	3.65 ± 0.77	3.03 ± 0.82	4.09 ± 0.29	0.009
t2	3.48 ± 0.81	2.99 ± 0.85	3.84 ± 0.62	0.07
t3	3.55 ± 0.83	2.96 ± 0.85	3.98 ± 0.52	0.03
t4	3.40 ± 0.78	2.86 ± 0.82	3.79 ± 0.49	0.03
p*	0.008	0.03	0.03
QI (L/min/m2)
t1	0.61 ± 0.22	0.47 ± 0.13	0.72 ± 0.23	0.06
t2	0.56 ± 0.19	0.43 ± 0.15	0.66 ± 0.18	0.04
t3	0.54 ± 0.22	0.39 ± 0.14	0.64 ± 0.21	0.04
t4	0.52 ± 0.20	0.39 ± 0.15	0.61 ± 0.19	0.07
p*	0.003	0.001	p = 0.07
ICG-DR (%/min)
t1	19.3 ± 6.2	16.2 ± 4.2	21.5 ± 6.6	0.15
t2	18.8 ± 5.8	15.8 ± 4.2	20.9 ± 6.0	0.14
t3	18.3 ± 5.5	15.7 ± 4.2	20.2 ± 5.8	0.17
t4	18.2 ± 5.2	15.8 ± 4.5	19.9 ± 5.3	0.19
p*	0.001	0.29	0.002
RI (mmHg∙s∙m2/mL)
t1	12.40 ± 4.21	15.71 ± 4.23	10.03 ± 2.21	0.01
t2	13.30 ± 5.43	17.64 ± 5.85	10.19 ± 2.06	0.01
t3	14.27 ± 6.18	19.65 ± 5.99	10.43 ± 2.19	0.004
t4	14.94 ± 6.36	20.29 ± 6.46	11.11 ± 2.29	0.005
p*	0.001	0.01	0.18

n: number of subjects; MAP: mean arterial pressure; HR: heart rate: Hct: hematocrit: V_p: plasma volume: QI: hepato-splanchnic blood flow index: ICG-DR, Indocyanine green disappearance rate: RI, hepato-splanchnic vascular resistance index; p*: probability for single factor variance analyses with repeated measurement; p ⁺: probability for two sample t-test for comparison between diabetics and non-diabetics